The authors report a new type of genetic alteration in lung adenocarcinoma. Fusions of KIF5B with RET kinase are found in 1–2% of lung cancer patients, segregate from other known alterations and can potentially be targeted using RET kinase inhibitors.
- Takashi Kohno
- Hitoshi Ichikawa
- Tatsuhiro Shibata